25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Atossa Genetics Inc
Buy, Hold or Sell?

Let's analyze Atossa Genetics Inc together

I guess you are interested in Atossa Genetics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Atossa Genetics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Atossa Genetics Inc

I send you an email if I find something interesting about Atossa Genetics Inc.

1. Quick Overview

1.1. Quick analysis of Atossa Genetics Inc (30 sec.)










1.2. What can you expect buying and holding a share of Atossa Genetics Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
5.0%

What is your share worth?

Current worth
$0.59
Expected worth in 1 year
$0.39
How sure are you?
30.0%

+ What do you gain per year?

Total Gains per Share
$-0.20
Return On Investment
-17.4%

For what price can you sell your share?

Current Price per Share
$1.12
Expected price per share
$1.05 - $1.17
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Atossa Genetics Inc (5 min.)




Live pricePrice per Share (EOD)
$1.12
Intrinsic Value Per Share
$-1.81 - $-1.12
Total Value Per Share
$-1.23 - $-0.54

2.2. Growth of Atossa Genetics Inc (5 min.)




Is Atossa Genetics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$73.6m$108.5m-$25.9m-31.4%

How much money is Atossa Genetics Inc making?

Current yearPrevious yearGrowGrow %
Making money-$6.7m-$7m$363.2k5.4%
Net Profit Margin-8,163.9%0.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Atossa Genetics Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#392 / 944

Most Revenue
#762 / 944

Most Profit
#481 / 944

Most Efficient
#858 / 944
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Atossa Genetics Inc?

Welcome investor! Atossa Genetics Inc's management wants to use your money to grow the business. In return you get a share of Atossa Genetics Inc.

First you should know what it really means to hold a share of Atossa Genetics Inc. And how you can make/lose money.

Speculation

The Price per Share of Atossa Genetics Inc is $1.12. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Atossa Genetics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Atossa Genetics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.59. Based on the TTM, the Book Value Change Per Share is $-0.05 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.05 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Atossa Genetics Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.06-5.1%-0.05-4.8%-0.06-5.3%-0.05-4.3%-0.04-3.5%
Usd Book Value Change Per Share-0.05-4.6%-0.05-4.4%-0.05-4.4%0.022.1%0.011.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.3%0.000.2%
Usd Total Gains Per Share-0.05-4.6%-0.05-4.4%-0.05-4.4%0.032.4%0.011.2%
Usd Price Per Share1.52-1.35-0.81-1.76-1.51-
Price to Earnings Ratio-6.61--6.50--3.42--11.08--2.50-
Price-to-Total Gains Ratio-29.50--28.66--16.37--21.57-13.93-
Price to Book Ratio2.60-2.08-0.96-7.49-14.87-
Price-to-Total Gains Ratio-29.50--28.66--16.37--21.57-13.93-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.12
Number of shares892
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.050.02
Usd Total Gains Per Share-0.050.03
Gains per Quarter (892 shares)-43.5523.99
Gains per Year (892 shares)-174.2295.96
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-174-184138386
20-348-35826166182
30-523-53238250278
40-697-70651333374
50-871-88064416470
60-1045-105477499566
70-1220-122889582662
80-1394-1402102666758
90-1568-1576115749854
100-1742-1750128832950

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%1.039.00.02.5%1.056.00.01.8%
Book Value Change Per Share0.04.00.00.0%0.012.00.00.0%4.016.00.020.0%12.028.00.030.0%19.036.02.033.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%2.00.018.010.0%2.00.038.05.0%3.00.054.05.3%
Total Gains per Share0.04.00.00.0%0.012.00.00.0%4.016.00.020.0%12.028.00.030.0%19.036.02.033.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Atossa Genetics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.052-0.049-5%-0.049-4%0.023-321%0.012-544%
Book Value Per Share--0.5860.657-11%0.859-32%0.708-17%0.387+52%
Current Ratio--13.30415.401-14%29.430-55%33.478-60%19.373-31%
Debt To Asset Ratio--0.0730.063+16%0.034+114%0.068+7%0.145-50%
Debt To Equity Ratio--0.0790.067+17%0.035+123%0.084-6%0.195-60%
Dividend Per Share----0%-0%0.004-100%0.002-100%
Enterprise Value--260187520.000245735847.500+6%200913234.525+30%305064773.885-15%234526410.700+11%
Eps---0.057-0.053-7%-0.059+3%-0.048-16%-0.039-32%
Ev To Ebitda Ratio---10.194-8.597-16%-7.880-23%-15.014+47%-14.592+43%
Ev To Sales Ratio--infinfnan%infnan%infnan%infnan%
Free Cash Flow Per Share---0.038-0.039+3%-0.039+4%-0.034-9%-0.026-31%
Free Cash Flow To Equity Per Share---0.038-0.038+1%-0.016-58%0.038-198%0.025-251%
Gross Profit Margin--1.0001.108-10%1.0000%1.022-2%1.037-4%
Intrinsic Value_10Y_max---1.121--------
Intrinsic Value_10Y_min---1.812--------
Intrinsic Value_1Y_max---0.105--------
Intrinsic Value_1Y_min---0.162--------
Intrinsic Value_3Y_max---0.321--------
Intrinsic Value_3Y_min---0.507--------
Intrinsic Value_5Y_max---0.544--------
Intrinsic Value_5Y_min---0.870--------
Market Cap140897120.000-36%191217520.000169516847.500+13%102726984.525+86%221654185.885-14%189714698.525+1%
Net Profit Margin----81.6390%-0%-16.3280%-8.6410%
Operating Margin----96.9440%-0%-19.3890%-10.1900%
Operating Ratio---96.944-100%-0%19.389-100%10.192-100%
Pb Ratio1.912-36%2.5952.080+25%0.961+170%7.487-65%14.870-83%
Pe Ratio-4.872+26%-6.612-6.500-2%-3.416-48%-11.082+68%-2.500-62%
Price Per Share1.120-36%1.5201.348+13%0.812+87%1.759-14%1.506+1%
Price To Free Cash Flow Ratio-7.400+26%-10.043-8.825-12%-5.458-46%-14.866+48%-13.171+31%
Price To Total Gains Ratio-21.740+26%-29.504-28.657-3%-16.371-45%-21.575-27%13.932-312%
Quick Ratio--12.90014.841-13%27.920-54%32.245-60%18.651-31%
Return On Assets---0.091-0.077-16%-0.064-30%-0.107+18%-0.240+164%
Return On Equity---0.098-0.082-17%-0.066-33%-0.123+25%-0.316+222%
Total Gains Per Share---0.052-0.049-5%-0.049-4%0.027-292%0.013-484%
Usd Book Value--73681000.00082654500.000-11%108587000.000-32%89347839.200-18%48786512.775+51%
Usd Book Value Change Per Share---0.052-0.049-5%-0.049-4%0.023-321%0.012-544%
Usd Book Value Per Share--0.5860.657-11%0.859-32%0.708-17%0.387+52%
Usd Dividend Per Share----0%-0%0.004-100%0.002-100%
Usd Enterprise Value--260187520.000245735847.500+6%200913234.525+30%305064773.885-15%234526410.700+11%
Usd Eps---0.057-0.053-7%-0.059+3%-0.048-16%-0.039-32%
Usd Free Cash Flow---4760000.000-4892250.000+3%-4978750.000+5%-4325314.950-9%-3271083.025-31%
Usd Free Cash Flow Per Share---0.038-0.039+3%-0.039+4%-0.034-9%-0.026-31%
Usd Free Cash Flow To Equity Per Share---0.038-0.038+1%-0.016-58%0.038-198%0.025-251%
Usd Market Cap140897120.000-36%191217520.000169516847.500+13%102726984.525+86%221654185.885-14%189714698.525+1%
Usd Price Per Share1.120-36%1.5201.348+13%0.812+87%1.759-14%1.506+1%
Usd Profit---7230000.000-6727750.000-7%-7091000.000-2%-5785898.950-20%-4445236.900-39%
Usd Revenue---4500.000-100%-0%900.000-100%-120740.6000%
Usd Total Gains Per Share---0.052-0.049-5%-0.049-4%0.027-292%0.013-484%
 EOD+3 -5MRQTTM+13 -22YOY+12 -205Y+7 -3010Y+16 -20

3.3 Fundamental Score

Let's check the fundamental score of Atossa Genetics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-4.872
Price to Book Ratio (EOD)Between0-11.912
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than112.900
Current Ratio (MRQ)Greater than113.304
Debt to Asset Ratio (MRQ)Less than10.073
Debt to Equity Ratio (MRQ)Less than10.079
Return on Equity (MRQ)Greater than0.15-0.098
Return on Assets (MRQ)Greater than0.05-0.091
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Atossa Genetics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5033.724
Ma 20Greater thanMa 501.235
Ma 50Greater thanMa 1001.359
Ma 100Greater thanMa 2001.364
OpenGreater thanClose1.150
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Atossa Genetics Inc

Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in the United States. The company's lead drug candidate is oral (Z)-endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It also develops immunotherapy/chimeric antigen receptor therapy programs. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is headquartered in Seattle, Washington.

Fundamental data was last updated by Penke on 2024-12-05 13:08:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Atossa Genetics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Atossa Genetics Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Atossa Genetics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-8,163.9%+8,163.9%
TTM-8,163.9%YOY--8,163.9%
TTM-8,163.9%5Y-1,632.8%-6,531.1%
5Y-1,632.8%10Y-864.1%-768.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--108.6%+108.6%
TTM-8,163.9%-221.4%-7,942.5%
YOY--207.4%+207.4%
5Y-1,632.8%-346.2%-1,286.6%
10Y-864.1%-470.4%-393.7%
4.3.1.2. Return on Assets

Shows how efficient Atossa Genetics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Atossa Genetics Inc to the Biotechnology industry mean.
  • -9.1% Return on Assets means that Atossa Genetics Inc generated $-0.09 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Atossa Genetics Inc:

  • The MRQ is -9.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -7.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-9.1%TTM-7.7%-1.4%
TTM-7.7%YOY-6.4%-1.3%
TTM-7.7%5Y-10.7%+3.1%
5Y-10.7%10Y-24.0%+13.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.1%-11.6%+2.5%
TTM-7.7%-12.0%+4.3%
YOY-6.4%-11.2%+4.8%
5Y-10.7%-12.6%+1.9%
10Y-24.0%-14.1%-9.9%
4.3.1.3. Return on Equity

Shows how efficient Atossa Genetics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Atossa Genetics Inc to the Biotechnology industry mean.
  • -9.8% Return on Equity means Atossa Genetics Inc generated $-0.10 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Atossa Genetics Inc:

  • The MRQ is -9.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -8.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-9.8%TTM-8.2%-1.6%
TTM-8.2%YOY-6.6%-1.6%
TTM-8.2%5Y-12.3%+4.1%
5Y-12.3%10Y-31.6%+19.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.8%-14.5%+4.7%
TTM-8.2%-16.0%+7.8%
YOY-6.6%-14.6%+8.0%
5Y-12.3%-18.5%+6.2%
10Y-31.6%-19.2%-12.4%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Atossa Genetics Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Atossa Genetics Inc is operating .

  • Measures how much profit Atossa Genetics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Atossa Genetics Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Atossa Genetics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-9,694.4%+9,694.4%
TTM-9,694.4%YOY--9,694.4%
TTM-9,694.4%5Y-1,938.9%-7,755.6%
5Y-1,938.9%10Y-1,019.0%-919.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--204.0%+204.0%
TTM-9,694.4%-316.8%-9,377.6%
YOY--215.6%+215.6%
5Y-1,938.9%-376.1%-1,562.8%
10Y-1,019.0%-480.3%-538.7%
4.3.2.2. Operating Ratio

Measures how efficient Atossa Genetics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Atossa Genetics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM96.944-96.944
TTM96.944YOY-+96.944
TTM96.9445Y19.389+77.556
5Y19.38910Y10.192+9.197
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.284-2.284
TTM96.9443.198+93.746
YOY-3.247-3.247
5Y19.3894.651+14.738
10Y10.1926.419+3.773
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Atossa Genetics Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Atossa Genetics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 13.30 means the company has $13.30 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Atossa Genetics Inc:

  • The MRQ is 13.304. The company is very able to pay all its short-term debts. +2
  • The TTM is 15.401. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ13.304TTM15.401-2.096
TTM15.401YOY29.430-14.029
TTM15.4015Y33.478-18.078
5Y33.47810Y19.373+14.105
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ13.3043.586+9.718
TTM15.4013.869+11.532
YOY29.4304.644+24.786
5Y33.4785.971+27.507
10Y19.3736.240+13.133
4.4.3.2. Quick Ratio

Measures if Atossa Genetics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Atossa Genetics Inc to the Biotechnology industry mean.
  • A Quick Ratio of 12.90 means the company can pay off $12.90 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Atossa Genetics Inc:

  • The MRQ is 12.900. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 14.841. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ12.900TTM14.841-1.941
TTM14.841YOY27.920-13.079
TTM14.8415Y32.245-17.404
5Y32.24510Y18.651+13.594
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ12.9003.093+9.807
TTM14.8413.392+11.449
YOY27.9204.304+23.616
5Y32.2455.953+26.292
10Y18.6516.435+12.216
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Atossa Genetics Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Atossa Genetics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Atossa Genetics Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.07 means that Atossa Genetics Inc assets are financed with 7.3% credit (debt) and the remaining percentage (100% - 7.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Atossa Genetics Inc:

  • The MRQ is 0.073. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.063. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.073TTM0.063+0.010
TTM0.063YOY0.034+0.029
TTM0.0635Y0.068-0.005
5Y0.06810Y0.145-0.077
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0730.346-0.273
TTM0.0630.347-0.284
YOY0.0340.313-0.279
5Y0.0680.365-0.297
10Y0.1450.383-0.238
4.5.4.2. Debt to Equity Ratio

Measures if Atossa Genetics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Atossa Genetics Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 7.9% means that company has $0.08 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Atossa Genetics Inc:

  • The MRQ is 0.079. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.067. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.079TTM0.067+0.011
TTM0.067YOY0.035+0.032
TTM0.0675Y0.084-0.016
5Y0.08410Y0.195-0.112
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0790.393-0.314
TTM0.0670.432-0.365
YOY0.0350.388-0.353
5Y0.0840.455-0.371
10Y0.1950.498-0.303
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Atossa Genetics Inc generates.

  • Above 15 is considered overpriced but always compare Atossa Genetics Inc to the Biotechnology industry mean.
  • A PE ratio of -6.61 means the investor is paying $-6.61 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Atossa Genetics Inc:

  • The EOD is -4.872. Based on the earnings, the company is expensive. -2
  • The MRQ is -6.612. Based on the earnings, the company is expensive. -2
  • The TTM is -6.500. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.872MRQ-6.612+1.740
MRQ-6.612TTM-6.500-0.112
TTM-6.500YOY-3.416-3.084
TTM-6.5005Y-11.082+4.583
5Y-11.08210Y-2.500-8.582
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-4.872-2.180-2.692
MRQ-6.612-2.507-4.105
TTM-6.500-3.153-3.347
YOY-3.416-3.242-0.174
5Y-11.082-5.992-5.090
10Y-2.500-6.690+4.190
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Atossa Genetics Inc:

  • The EOD is -7.400. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -10.043. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -8.825. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.400MRQ-10.043+2.643
MRQ-10.043TTM-8.825-1.218
TTM-8.825YOY-5.458-3.367
TTM-8.8255Y-14.866+6.041
5Y-14.86610Y-13.171-1.695
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-7.400-2.879-4.521
MRQ-10.043-3.276-6.767
TTM-8.825-3.669-5.156
YOY-5.458-4.485-0.973
5Y-14.866-8.015-6.851
10Y-13.171-9.197-3.974
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Atossa Genetics Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.60 means the investor is paying $2.60 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Atossa Genetics Inc:

  • The EOD is 1.912. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.595. Based on the equity, the company is underpriced. +1
  • The TTM is 2.080. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.912MRQ2.595-0.683
MRQ2.595TTM2.080+0.515
TTM2.080YOY0.961+1.119
TTM2.0805Y7.487-5.407
5Y7.48710Y14.870-7.383
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.9121.964-0.052
MRQ2.5952.056+0.539
TTM2.0802.388-0.308
YOY0.9612.460-1.499
5Y7.4873.697+3.790
10Y14.8704.324+10.546
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Atossa Genetics Inc.

4.8.1. Institutions holding Atossa Genetics Inc

Institutions are holding 28.218% of the shares of Atossa Genetics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-06-30BlackRock Inc7.31080.000391970406445777234.2843
2024-09-30Vanguard Group Inc5.2450.000265982961124191.7333
2024-09-30Geode Capital Management, LLC2.23720.00042814446447621.6161
2024-09-30State Street Corp1.3770.00011732221691804.1598
2024-09-30Renaissance Technologies Corp1.04140.0031310070-240840-15.5289
2024-09-30Northern Trust Corp0.75850.0002954199686991257.0997
2024-09-30Morgan Stanley - Brokerage Accounts0.36370.0001457520-454786-49.8502
2024-09-30Charles Schwab Investment Management Inc0.27630.0001347610-22378-6.0483
2024-09-30Bank of New York Mellon Corp0.24140.0001303649-108018-26.2392
2024-06-30Jane Street Group LLC0.20670.00012600812600810
2024-09-30Goldman Sachs Group Inc0.1980.0001249128146463142.6611
2024-09-30Connor Clark & Lunn Inv Mgmt Ltd0.15880.0015199754-9487-4.534
2024-09-30Qube Research & Technologies0.15550.00041955893816324.2419
2024-09-30Nuveen Asset Management, LLC0.13570.000117073300
2024-09-30Barclays PLC0.13330.0001167718123683280.8743
2024-09-30Citadel Advisors Llc0.12870.0001161899-39599-19.6523
2024-09-30JPMorgan Chase & Co0.119014964295643177.1199
2024-09-30Rhumbline Advisers0.09780.0002123039-12079-8.9396
2024-06-30Mariner Wealth Advisors LLC0.08420.000210591000
2024-06-30Bank of America Corp0.08401056722574132.204
Total 20.3530.007325604216+7161716+28.0%

4.9.2. Funds holding Atossa Genetics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-10-31Vanguard Total Stock Mkt Idx Inv3.13150.0003393944100
2024-11-27iShares Russell 2000 ETF2.79580.00563517118-7350-0.2085
2024-10-31Vanguard Institutional Extnd Mkt Idx Tr1.32570.0021166774800
2024-09-30Fidelity Small Cap Index1.03620.00721303506-689-0.0528
2024-11-27iShares Russell 2000 Value ETF0.87090.0101109562814140.1292
2024-09-30Fidelity Extended Market Index0.54980.0025691600-172-0.0249
2024-10-31State St Russell Sm Cap® Indx SL Cl I0.45950.008357800000
2024-10-31Vanguard Russell 2000 ETF0.45820.0065576474-3604-0.6213
2024-09-30NT R2000 Index Fund - NL0.24010.0073020383020380
2024-10-31Schwab Small Cap Index0.23980.006630164800
2024-11-27iShares Micro-Cap ETF0.22890.03728800300
2024-10-31iShares Russell 2000 Small-Cap Idx Instl0.20050.007125219900
2024-10-31BlackRock Advantage Small Cap Core Instl0.19620.008424684200
2024-09-30BlackRock Extended Equity Market K0.19360.0025243563-103-0.0423
2024-09-30NT R2000 Index Fund - DC - NL - 20.19230.0072418542418540
2024-11-27iShares Russell 2000 Growth ETF0.18280.0022229950195199.2757
2024-09-30Fidelity Total Market Index0.17480.0003219963-540-0.2449
2024-09-30Northern Trust Russell 2000 Value Index0.17280.01242173902173900
2024-09-30NT R2000 Value Index Fund - L0.17280.01232173902173900
2024-09-30Russell 2000 Index Non-Lendable Fund E0.17110.0075215186-33264-13.3886
Total 12.99330.152916345541+953883+5.8%

5.3. Insider Transactions

Insiders are holding 0.058% of the shares of Atossa Genetics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-04-10Jonathan FinnBUY250001.77
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets79,477
Total Liabilities5,796
Total Stockholder Equity73,681
 As reported
Total Liabilities 5,796
Total Stockholder Equity+ 73,681
Total Assets = 79,477

Assets

Total Assets79,477
Total Current Assets77,111
Long-term Assets2,366
Total Current Assets
Cash And Cash Equivalents 74,766
Other Current Assets 2,345
Total Current Assets  (as reported)77,111
Total Current Assets  (calculated)77,111
+/-0
Long-term Assets
Long-term Assets Other 2,366
Long-term Assets  (as reported)2,366
Long-term Assets  (calculated)2,366
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities5,796
Long-term Liabilities0
Total Stockholder Equity73,681
Total Current Liabilities
Accounts payable 1,561
Other Current Liabilities 4,235
Total Current Liabilities  (as reported)5,796
Total Current Liabilities  (calculated)5,796
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock22,882
Retained Earnings -205,445
Other Stockholders Equity 256,244
Total Stockholder Equity (as reported)73,681
Total Stockholder Equity (calculated)73,681
+/-0
Other
Capital Stock22,882
Cash and Short Term Investments 74,766
Common Stock Shares Outstanding 125,773
Liabilities and Stockholders Equity 79,477
Net Debt -74,766
Net Invested Capital 73,681
Net Working Capital 71,315



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302009-12-312009-09-30
> Total Assets 
0
85
41
32
15
0
0
4,135
3,072
1,366
843
5,692
6,826
8,912
10,055
13,482
12,009
22,383
19,819
16,772
11,764
13,803
16,561
12,357
6,243
5,100
3,285
6,278
4,144
2,303
4,709
3,635
8,164
5,980
16,578
14,124
11,720
21,025
18,609
16,597
14,490
11,812
10,206
11,438
42,839
141,081
145,868
143,024
141,262
137,478
134,048
126,724
123,532
116,200
108,355
101,695
96,252
91,087
85,858
79,477
79,47785,85891,08796,252101,695108,355116,200123,532126,724134,048137,478141,262143,024145,868141,08142,83911,43810,20611,81214,49016,59718,60921,02511,72014,12416,5785,9808,1643,6354,7092,3034,1446,2783,2855,1006,24312,35716,56113,80311,76416,77219,81922,38312,00913,48210,0558,9126,8265,6928431,3663,0724,13500153241850
   > Total Current Assets 
0
0
40
31
10
0
0
4,050
2,945
1,215
701
885
1,989
4,166
5,355
8,595
7,414
17,700
14,674
11,716
9,086
11,367
13,756
9,542
4,295
3,386
1,455
4,564
3,255
1,517
3,976
2,950
7,898
5,735
16,408
13,923
11,549
20,780
18,388
16,401
14,319
11,667
10,062
11,318
42,770
141,031
145,831
142,987
141,240
136,848
133,421
123,395
118,197
110,869
106,003
97,648
92,219
87,055
81,718
77,111
77,11181,71887,05592,21997,648106,003110,869118,197123,395133,421136,848141,240142,987145,831141,03142,77011,31810,06211,66714,31916,40118,38820,78011,54913,92316,4085,7357,8982,9503,9761,5173,2554,5641,4553,3864,2959,54213,75611,3679,08611,71614,67417,7007,4148,5955,3554,1661,9898857011,2152,9454,0500010314000
       Cash And Cash Equivalents 
0
84
32
30
10
0
0
3,006
1,911
899
90
419
1,725
1,385
2,487
7,737
6,342
16,591
14,298
11,374
8,501
9,728
11,403
7,839
3,716
2,883
1,191
4,388
3,028
1,167
3,690
2,734
7,217
4,780
15,237
12,936
10,380
19,568
17,059
15,290
12,581
9,351
7,463
9,106
39,554
137,574
142,433
140,041
136,377
131,486
125,537
117,367
110,890
103,868
99,390
94,031
88,570
84,070
79,526
74,766
74,76679,52684,07088,57094,03199,390103,868110,890117,367125,537131,486136,377140,041142,433137,57439,5549,1067,4639,35112,58115,29017,05919,56810,38012,93615,2374,7807,2172,7343,6901,1673,0284,3881,1912,8833,7167,83911,4039,7288,50111,37414,29816,5916,3427,7372,4871,3851,725419908991,9113,00600103032840
       Short-term Investments 
0
0
0
0
0
0
0
0
1,000
0
251
250
0
0
0
0
0
0
0
0
0
0
0
275
275
275
55
55
55
55
55
55
55
55
55
55
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000555555555555555555552752752750000000000025025101,00000000000
       Net Receivables 
0
0
0
0
0
0
0
0
1
46
179
175
142
259
520
299
139
91
48
29
298
1,280
2,012
1,055
76
76
268
228
194
149
3
4
358
396
626
480
518
238
406
569
740
734
761
439
635
720
817
935
1,072
668
900
610
743
738
737
28
-1
0
-1,095
0
0-1,0950-1287377387436109006681,0729358177206354397617347405694062385184806263963584314919422826876761,0552,0121,28029829489113929952025914217517946100000000
       Other Current Assets 
0
0
8
2
0
0
0
2
2
2
431
2
123
2,521
2,348
559
933
1,018
325
267
247
264
239
477
111
503
264
176
14
350
283
212
16
9
50
162
31
28
0
2
26
135
264
179
658
77
79
18
1,193
710
1,570
201
2,423
858
7
7
3,649
1,723
1,097
2,345
2,3451,0971,7233,649778582,4232011,5707101,1931879776581792641352620283116250916212283350141762645031114772392642472673251,0189335592,3482,52112324312220002800
   > Long-term Assets 
0
0
1
1
5
0
0
85
126
151
142
4,807
4,837
4,746
4,700
4,887
4,595
4,683
5,145
5,056
2,678
2,436
2,806
2,815
1,948
1,714
1,830
1,714
890
786
733
685
266
245
170
201
171
245
221
196
170
145
144
119
69
49
37
37
22
630
627
3,329
5,335
5,331
2,352
4,047
4,033
4,032
4,140
2,366
2,3664,1404,0324,0334,0472,3525,3315,3353,32962763022373749691191441451701962212451712011702452666857337868901,7141,8301,7141,9482,8152,8062,4362,6785,0565,1454,6834,5954,8874,7004,7464,8374,807142151126850051100
       Property Plant Equipment 
0
0
0
0
0
0
0
34
80
76
72
67
160
150
206
443
163
130
128
185
358
382
360
485
172
146
114
85
55
28
19
14
11
60
61
58
54
136
120
102
84
67
74
57
39
24
19
23
20
0
0
0
0
0
0
0
0
0
0
0
000000000002023192439577467841021201365458616011141928558511414617248536038235818512813016344320615016067727680340000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,700
4,700
4,700
1,710
1,710
0
1,710
1,710
0
01,7101,71001,7101,7104,7004,7002,700000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
45
41
37
32
4,703
4,640
4,559
4,458
4,407
4,396
4,492
4,454
4,365
1,921
1,878
1,822
1,769
1,701
1,492
1,447
1,402
640
610
586
561
76
71
60
55
99
92
84
76
69
61
53
45
13
9
4
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000049134553616976849299556071765615866106401,4021,4471,4921,7011,7691,8221,8781,9214,3654,4544,4924,3964,4074,4584,5594,6404,703323741450000000
       Other Assets 
0
1
0
0
5
0
0
0
46
0
70
4,740
4,677
4,596
4,494
4,444
4,432
4,553
5,017
4,871
2,320
2,054
2,445
2,330
1,776
1,568
1,715
1,629
834
758
714
671
255
115
49
89
17
17
17
17
0
17
17
74
56
16
13
13
2
630
627
0
635
0
0
0
0
0
0
0
0000000635062763021313165674171701717171789491152556717147588341,6291,7151,5681,7762,3302,4452,0542,3204,8715,0174,5534,4324,4444,4944,5964,6774,7407004600050010
> Total Liabilities 
0
0
98
559
867
0
0
1,399
1,512
779
1,398
2,291
1,651
1,936
1,774
1,942
1,407
1,082
1,563
1,540
2,266
3,519
3,436
3,298
2,502
1,327
874
864
1,047
775
1,906
1,072
1,225
721
3,011
3,555
2,915
1,529
1,057
1,578
1,334
916
1,831
1,567
15,672
1,379
1,796
1,676
3,126
2,322
3,792
2,868
5,568
2,944
3,478
3,444
5,236
5,328
5,696
5,796
5,7965,6965,3285,2363,4443,4782,9445,5682,8683,7922,3223,1261,6761,7961,37915,6721,5671,8319161,3341,5781,0571,5292,9153,5553,0117211,2251,0721,9067751,0478648741,3272,5023,2983,4363,5192,2661,5401,5631,0821,4071,9421,7741,9361,6512,2911,3987791,5121,399008675599800
   > Total Current Liabilities 
0
54
98
559
867
0
0
1,399
1,512
779
1,398
2,291
1,651
1,936
1,774
1,942
1,407
1,082
1,563
1,540
2,214
3,487
3,414
3,293
2,502
1,327
874
864
1,047
775
1,906
1,072
1,225
721
3,011
3,555
2,915
1,491
1,033
1,564
1,323
908
1,827
1,565
15,672
1,379
1,796
1,676
3,126
2,322
3,792
2,868
5,568
2,944
3,478
3,444
5,236
5,328
5,696
5,796
5,7965,6965,3285,2363,4443,4782,9445,5682,8683,7922,3223,1261,6761,7961,37915,6721,5651,8279081,3231,5641,0331,4912,9153,5553,0117211,2251,0721,9067751,0478648741,3272,5023,2933,4143,4872,2141,5401,5631,0821,4071,9421,7741,9361,6512,2911,3987791,5121,3990086755998540
       Short-term Debt 
0
0
5
107
189
0
0
1,010
1,005
250
250
330
0
0
1,486
1,427
1,114
0
0
0
76
80
72
0
0
0
0
0
0
0
0
0
0
0
0
0
0
51
52
49
39
29
40
30
18
8
5
1
0
0
0
0
0
0
0
0
0
0
0
0
0000000000001581830402939495251000000000000007280760001,1141,4271,486003302502501,0051,01000189107500
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
51
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000510000000000000000000000000000000000000
       Accounts payable 
0
0
0
0
0
0
0
0
65
97
71
72
68
35
184
31
10
196
790
439
594
966
581
1,179
814
429
283
197
254
387
496
380
335
168
191
551
353
464
318
501
293
356
1,033
683
1,589
722
538
668
1,717
1,596
2,052
1,653
2,965
1,444
1,174
718
806
1,230
1,056
1,561
1,5611,0561,2308067181,1741,4442,9651,6532,0521,5961,7176685387221,5896831,0333562935013184643535511911683353804963872541972834298141,179581966594439790196103118435687271976500000000
       Other Current Liabilities 
0
49
93
452
678
0
0
389
442
433
1,077
1,969
1,582
1,902
32
423
235
1,047
773
1,100
42
43
20
2,113
1,687
898
591
666
793
388
1,410
691
891
552
2,820
3,005
2,562
10
20
18
13
3
6
15
13,008
8
21
18
1,409
726
1,740
1,215
2,603
1,500
2,304
2,726
4,430
4,098
4,640
4,235
4,2354,6404,0984,4302,7262,3041,5002,6031,2151,7407261,4091821813,0081563131820102,5623,0052,8205528916911,4103887936665918981,6872,1132043421,1007731,047235423321,9021,5821,9691,0774334423890067845293490
   > Long-term Liabilities 
0
0
5
107
189
0
0
1,010
1,070
347
321
322
68
35
257
92
58
35
790
439
52
32
23
6
814
429
283
197
254
387
496
380
335
168
191
551
353
37
24
14
11
8
5
1
1,607
730
543
669
1,717
1,596
2,052
1,653
2,965
1,444
0
0
0
0
0
0
0000001,4442,9651,6532,0521,5961,7176695437301,60715811142437353551191168335380496387254197283429814623325243979035589225735683223213471,0701,01000189107500
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
49
25
13
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000013254900000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
7
10
5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000005107200000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
7
10
6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000006107200000000000000000000
> Total Stockholder Equity
0
0
-57
-527
-852
0
0
2,736
1,560
587
-555
3,402
5,176
6,976
8,281
11,540
10,602
21,301
18,256
15,233
9,498
10,284
13,125
9,059
3,742
3,773
2,410
5,414
3,097
1,528
2,804
2,563
6,939
5,260
13,567
10,569
8,805
19,496
17,552
15,018
13,156
10,896
8,374
9,871
27,168
139,701
144,072
141,348
138,136
135,156
130,256
123,856
117,964
113,256
104,877
98,251
91,016
85,759
80,162
73,681
73,68180,16285,75991,01698,251104,877113,256117,964123,856130,256135,156138,136141,348144,072139,70127,1689,8718,37410,89613,15615,01817,55219,4968,80510,56913,5675,2606,9392,5632,8041,5283,0975,4142,4103,7733,7429,05913,12510,2849,49815,23318,25621,30110,60211,5408,2816,9765,1763,402-5555871,5602,73600-852-527-5700
   Common Stock
0
5
6
6
6
0
0
11
11
11
11
12
13
15
15
17
19
24
24
25
25
27
29
30
33
39
40
57
57
57
150
210
477
477
877
994
1,052
1,642
1,643
1,644
1,644
1,644
1,675
1,884
8,559
21,748
22,667
22,792
22,792
22,792
22,792
22,792
22,792
22,792
22,792
22,792
22,792
22,829
22,874
22,882
22,88222,87422,82922,79222,79222,79222,79222,79222,79222,79222,79222,79222,79222,66721,7488,5591,8841,6751,6441,6441,6441,6431,6421,05299487747747721015057575740393330292725252424191715151312111111110066650
   Retained Earnings Total Equity00000-172,305-162,475-156,194-148,703-140,691-134,020-129,234-124,402-119,205-112,166-111,899-104,416-100,925-97,018-94,071-91,453-88,167-80,905-76,831-74,753-71,443-67,301-65,426-63,433-61,249-59,007-57,304-54,780-54,985-53,262-50,935-45,973-41,655-38,510-35,175-29,362-26,116-22,928-20,517-17,759-14,257-11,673-9,732-8,02600000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
-1
0
-10
-15
-19
-31
-41
-67
-94
-272
-294
-313
-338
-259
-290
-322
-356
-114
-144
-176
-206
-155
-143
-152
-156
-159
0
0
0
0
0
0
0
-151
-151
0
0
0
0
0
0
-582
-582
0
-54
-582
0
-582
254,886
0
0
0
0
0000254,886-5820-582-540-582-582000000-151-1510000000-159-156-152-143-155-206-176-144-114-356-322-290-259-338-313-294-272-94-67-41-31-19-15-100-10000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
11,416
14,895
18,634
22,523
29,281
31,100
44,205
44,347
44,570
44,648
48,766
54,751
55,002
54,644
56,997
57,356
60,138
60,344
60,479
63,872
65,786
71,888
72,083
78,331
84,328
84,584
98,759
104,076
104,828
105,583
106,271
107,624
112,403
130,508
230,119
240,610
242,958
244,578
246,384
248,155
249,821
251,366
252,939
254,542
0
0
0
0
0
00000254,542252,939251,366249,821248,155246,384244,578242,958240,610230,119130,508112,403107,624106,271105,583104,828104,07698,75984,58484,32878,33172,08371,88865,78663,87260,47960,34460,13857,35656,99754,64455,00254,75148,76644,64844,57044,34744,20531,10029,28122,52318,63414,89511,41600000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
322
335
352
0
0
6,173
6,201
6,301
6,331
11,435
14,926
18,675
22,589
29,375
31,372
44,498
44,661
44,908
44,907
49,056
55,073
55,358
54,758
57,141
57,532
60,344
60,499
60,622
64,054
65,942
72,047
72,083
84,133
84,328
84,584
98,759
104,076
104,828
105,734
106,271
107,624
112,403
130,508
230,119
240,610
242,958
243,996
246,384
247,573
249,239
251,366
252,357
254,390
-1,475
254,512
255,096
255,503
256,244
256,244255,503255,096254,512-1,475254,390252,357251,366249,239247,573246,384243,996242,958240,610230,119130,508112,403107,624106,271105,734104,828104,07698,75984,58484,32884,13372,08372,04765,94264,05460,62260,49960,34457,53257,14154,75855,35855,07349,05644,90744,90844,66144,49831,37229,37522,58918,67514,92611,4356,3316,3016,2016,1730035233532200



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.